AdvantageClub.ai raises $4 Million from Axilor Ventures to expand in the US and Asia and add New Product Lines

2024-12-04 AdvantageClub.ai HaiPress

MANILA,Philippines,Dec. 2,2024 -- AdvantageClub.ai,a leader in employee engagement solutions,has raised $4 million in its latest funding round,bringing its total funding to $11 million. The round was led by Axilor Ventures,with participation from AFG Ventures,Prasanna Sarkar (ex-CTO of Rippling),Bytez Ventures,and existing investors.


Sourabh Deorah,CEO & Co Founder and Smiti Bhatt Deorah,COO & CO founder of AdvantageClub.ai

They plan to use the funds to strengthen its presence in the US and Asia,where company has already seen success. The company will also focus on expanding its product suite in employee recognition,rewards,and engagement,with plans to introduce new tools and features to enhance employee experience.

Sourabh Deorah,CEO & Co-founder of AdvantageClub.ai,expressed excitement about the investment from investors,saying,"This funding will help us double down on the US and Asia,expand our product suite,and continue building AI-driven solutions like Adva to engage employees in new ways." COO & Co-founder Smiti Bhatt Deorah added,"Our employee-first approach has made us the top choice for organizations,we win 65-70% of new recognition deals in Asia and have expanded successfully into the US."

Ganapathy Venugopal,founder and CEO of Axilor Ventures,the lead investor in this round,has been a long-time supporter of AdvantageClub.ai said,"Companies are in search of good options to improve employee engagement and strengthen their employer brand. AdvantageClub.ai's personalised,scalable and global platform offers a best-in-class solution to employers who put their employees first. We are excited to continue our partnership with Sourabh and Smiti as they look at their next phase of exciting growth."

About AdvantageClub.ai

AdvantageClub.ai is a global AI powered employee engagement and rewards platform with offerings like rewards & recognition,flexible benefits,surveys,moments that matter,and communities on a single platform. AdvantageClub.ai has over 5 million users,a presence in over 100+ countries,1000+ clients,and 10,000+ redemption options. Founded in 2016 by UCLA postgraduates Sourabh and Smiti Deorah,AdvantageClub.ai leverages AI,data mining,and analytics to revolutionize employee engagement. Headquartered in San Francisco,AdvantageClub.ai has an impressive client portfolio featuring Concentrix,Franke,Afni,Security Bank,IGT Solutions,Qiagen,BCG,and many more.

Disclaimer: This article is reproduced from other media. The purpose of reprinting is to convey more information. It does not mean that this website agrees with its views and is responsible for its authenticity, and does not bear any legal responsibility. All resources on this site are collected on the Internet. The purpose of sharing is for everyone's learning and reference only. If there is copyright or intellectual property infringement, please leave us a message.

Newest

1Cangxi County Holds 2026 New Year's Cultural Performance for the Public

Cangxi County Holds 2026 New Year's Cultural Performance for the Public

2The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

3The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

4Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

5Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

6Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

©copyright 2009-2020 Singapore Info Map